Navigation Links
NIH-funded genetic sequencing tool speeds drug discovery, disease diagnostics
Date:10/31/2012

Today physicists at Wake Forest University and NanoMedica, their biotechnology company partner, received a $700,000 grant from the National Institutes of Health (NIH) to bring to market a new drug-discovery tool using next-generation genetic sequencing.

The technology, Next-Gen Lab-on-Bead, would be the first bead-based drug-discovery tool to use the latest genetic sequencing technologies, making drug and diagnostics discovery significantly more efficient.

Pharmaceutical companies would use the technology as a sort of Google search for new drugs sending the scientists a protein marker of the disease for which they want to find a treatment, and letting Next-Gen Lab-on-Bead test millions of possibilities all at once.

"Next-gen is much faster and cheaper, and no one is using it for drug discovery as far as we know," said Martin Guthold, associate professor of physics and co-inventor of Next-Gen Lab-on-Bead. "It miniaturizes and massively parallelizes sequencing on beads in little wells, so we can do millions of sequencing actions in unison to find potential drug candidates to treat a specific disease."

The NIH awarded the funding through its Small Business Innovation Research program, so Wake Forest will share the funds with NanoMedica, a Winston-Salem company that has licensed the patent for Next-Gen Lab-on-Bead.

The technology uses a roughly one-inch-square chip, similar to a computer chip. A football-shaped area in the middle of the chip is filled with millions of wells. Each well contains a bead, to which the researchers attach a potential drug molecule.

"Each chip contains millions of potential drug candidates," Guthold said. "We know the position and identity of each, because we can associate a potential drug molecule with the sequence in each well."

To find a disease-drug match, a pharmaceutical company would supply the target for instance, a protein called Src kinase associated with many cancers. The researchers would combine the fluorescently labeled protein with a neutral solution and flow it over the chip.

If a well glows fluorescently, indicating that the protein target bound to the bead in the well, it contains a drug candidate that is potentially useful in treating the disease. The pharmaceutical company then can begin testing the drug in the lab.

Though the Wake Forest-NanoMedica research team has focused on drug discovery, Next-Gen Lab-on-Bead also could be used for more accurate, speedy medical diagnoses.

"If you want to see if a biopsy is cancerous, you could use diagnostic molecules that were discovered with this technology. If a biopsy sample binds to certain diagnostic molecules, then it's cancerous," Guthold said.

The research team includes Keith Bonin, Jed Macosko and Jason Gagliano of the Wake Forest physics department.

Wake Forest and NanoMedica also have received a two-year, $160,000 Collaborative Funding Grant from the North Carolina Biotechnology Center to refine Next-Gen Lab-on-Bead for commercial use.

"We have made a major commitment to purchasing expensive equipment that's beyond the realm of most startups, and that's a risk we took because we are confident that applying next-gen sequencing to drug discovery is really novel," said Roger Cubicciotti, NanoMedica president/CEO.

According to a recent report by Frost & Sullivan, next-generation genetic sequencing is expected to boom in the next five years as researchers explore drug-discovery and diagnostic applications. That will make it one of the fastest-growing markets in the biomedical industry, the report says.


'/>"/>

Contact: Katie Neal
nealkc@wfu.edu
336-758-6141
Wake Forest University
Source:Eurekalert

Related biology news :

1. NIH-funded researchers restore sense of smell in mice using genetic technique
2. NIH-funded study examines use of mobile technology to improve diet and physical activity behavior
3. Global genome effort seeks genetic roots of disease
4. Social factors trump genetic forces in forging friendships, CU-led study finds
5. Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
6. Researchers identify genetic basis of cardiac, craniofacial birth defects
7. Scientists deepen genetic understanding of MS
8. Far from random, evolution follows a predictable genetic pattern, Princeton researchers find
9. Pitt biologist receives $2 million to study genetic diversity of plants worldwide
10. Scientists uncover mechanism by which plants inherit epigenetic modifications
11. Men and women are different in terms of genetic predispositions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2016)... DUBLIN , Jan. 22, 2016 /PRNewswire/ ... announced the addition of the "Global ... report to their offering. --> ... of the "Global Biometrics Market in ... offering. --> Research and ...
(Date:1/20/2016)... LONDON , Jan. 20, 2016 A ... positioned to directly benefit from the explosion in genomics ... from Howe Sound Research. A range of dynamic trends ... ...... - personalized medicine - pharmacogenomics - pathogen ... economies with large markets - greater understanding of the ...
(Date:1/20/2016)... , Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... interface solutions, today announced sampling of S1423, its ... wearables and small screen applications including smartwatches, fitness ... Supporting round and rectangular shapes, as well as ... performance with moisture on screen, while wearing gloves, ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... is introducing a hybrid membership model which will provide ... joining or renewing through an organizational purchasing model. For ... employee in any size association or AMC office can ... benefits.   John H. Graham, IV , ... organizations of any size and their employees to gain ...
(Date:2/10/2016)... Feb. 10, 2016  Matchbook, Inc., a company ... growing biotech companies, announced today the appointment of ... Advisor. Jim brings nearly 25 years of experience ... having spent nearly two decades in executive level ... Procurement at Genzyme and, most recently headed global ...
(Date:2/10/2016)... ... 2016 , ... SonaCare Medical, LLC reports the introduction of ... monitoring. The inaugural launch of this new technology occurred over the course of ... to a HIFU technical expert at SonaCare Medical headquarters. , Sonalink allows ...
(Date:2/10/2016)... ... 10, 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused on ... today it has been selected to present at the Cavendish Global Health Impact Forum ... The purpose of the Forum is to help family offices and foundations develop ...
Breaking Biology Technology: